http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101629181-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate | 2009-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101629181-B1 |
| titleOfInvention | Pyrrole compounds |
| abstract | The present invention relates to a compound represented by the formula: or a salt thereof, or a pharmaceutical composition comprising the same: Wherein A is a pyridyl group having at least one substituent: (Wherein R 1 , R 2 and R 3 are each a hydrogen atom, a halogen atom, a C 1-6 alkyl group optionally substituted by halogen or a C 1-6 alkoxy group optionally substituted by halogen, and R 4 and R 6 are each is an optionally substituted C 1-6 alkyl group, a hydrogen atom, a halogen atom or halogen, R 5 is a hydrogen atom, a halogen atom, by an optionally substituted C 1-6 alkyl group or a halogen with a halogen an optionally substituted C 1-6 alkoxy group And R 7 is a hydrogen atom or a C 1-6 alkyl group optionally substituted by halogen). |
| priorityDate | 2008-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 461.